Les Sulewski
Stock Analyst at Truist Financial
(3.84)
# 1,838
Out of 4,352 analysts
185
Total ratings
48.4%
Success rate
7.8%
Average return
Main Sectors:
Stocks Rated by Les Sulewski
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRMD CorMedix | Maintained: Buy | n/a | $8.44 | - | 23 | May 15, 2026 | |
| COLL Collegium Pharmaceutical | Maintained: Buy | n/a | $33.61 | - | 20 | May 14, 2026 | |
| ANIP ANI Pharmaceuticals | Maintained: Hold | n/a | $78.51 | - | 25 | May 11, 2026 | |
| VTRS Viatris | Reiterated: Buy | $20 | $16.26 | +23.00% | 8 | May 8, 2026 | |
| VNDA Vanda Pharmaceuticals | Maintained: Buy | $18 | $6.45 | +179.07% | 4 | May 7, 2026 | |
| PCRX Pacira BioSciences | Maintained: Buy | n/a | $23.22 | - | 24 | May 1, 2026 | |
| TSX: BHC Bausch Health Companies Inc. | Reiterated: Hold | n/a | $7.41 | - | 18 | May 1, 2026 | |
| TEVA Teva Pharmaceutical Industries | Rated: Buy | $42 → $45 | $35.32 | +27.41% | 11 | Apr 30, 2026 | |
| AMRX Amneal Pharmaceuticals | Maintained: Buy | n/a | $13.17 | - | 21 | Apr 23, 2026 | |
| BTMD biote | Maintained: Buy | $5 → $4 | $2.00 | +100.00% | 19 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | €22.00 | $28.26 | n/a | 1 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $90.98 | n/a | 1 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23.47 → $19.33 | $17.09 | n/a | 5 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.46 | n/a | 5 | Jul 9, 2024 |
CorMedix
May 15, 2026
Maintained: Buy
Price Target: n/a
Current: $8.44
Upside: -
Collegium Pharmaceutical
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $33.61
Upside: -
ANI Pharmaceuticals
May 11, 2026
Maintained: Hold
Price Target: n/a
Current: $78.51
Upside: -
Viatris
May 8, 2026
Reiterated: Buy
Price Target: $20
Current: $16.26
Upside: +23.00%
Vanda Pharmaceuticals
May 7, 2026
Maintained: Buy
Price Target: $18
Current: $6.45
Upside: +179.07%
Pacira BioSciences
May 1, 2026
Maintained: Buy
Price Target: n/a
Current: $23.22
Upside: -
Bausch Health Companies Inc.
May 1, 2026
Reiterated: Hold
Price Target: n/a
Current: $7.41
Upside: -
Teva Pharmaceutical Industries
Apr 30, 2026
Rated: Buy
Price Target: $42 → $45
Current: $35.32
Upside: +27.41%
Amneal Pharmaceuticals
Apr 23, 2026
Maintained: Buy
Price Target: n/a
Current: $13.17
Upside: -
biote
Apr 16, 2026
Maintained: Buy
Price Target: $5 → $4
Current: $2.00
Upside: +100.00%
May 27, 2025
Initiated Coverage: Buy
Price Target: €22.00
Current: $28.26
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: n/a
Current: $90.98
Upside: n/a
Jul 26, 2024
Maintained: Buy
Price Target: $23.47 → $19.33
Current: $17.09
Upside: n/a
Jul 9, 2024
Rated: Hold
Price Target: n/a
Current: $0.46
Upside: n/a